Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Fecal bacteriotherapy Stories

2013-12-04 16:01:15

Infants and toddlers frequently carry toxigenic Clostridium difficile, usually with no harm to themselves, but can serve as a reservoir and spread the bacteria to adults in whom it can cause severe disease, according to a study by a team of Swedish researchers published ahead of print in the Journal of Clinical Microbiology. In the study, which involved following 42 children from birth to 1 ½ or 3 years, the investigators found that C. difficile strains persisted for more than six months...

2013-10-28 16:24:50

KIRKLAND, Wash., Oct. 28, 2013 /PRNewswire/ -- Traditionally, patients who contract C. difficile (C. diff)--an intestinal infection that causes severe cramping and diarrhea--have faced a treatment regimen filled with rounds of expensive antibiotics, each with their own troubling side effects and a less-than-spectacular success rate. According to the Centers for Disease Control and Prevention, rates of C. diff have increased nationwide over the past several years, resulting in half a...

Poop Pill Cures Intestinal Infections
2013-10-04 12:24:35

Michael Harper for redOrbit.com - Your Universe Online Recent studies have shown infections with the bacteria Clostridium difficile (C. diff) can be cured if other bacteria can be transplanted into the patient’s gut. Doctors from Amsterdam, Canada and elsewhere have successfully transferred these bacteria by means of fecal transplant, or placing a sterile stool sample from a healthy person into the patient’s stomach. Tests have shown this procedure is highly effective, curing up to 94...

2013-06-12 16:26:23

AGA Urges FDA to Streamline Process to Get Treatment to Patients BETHESDA, Md., June 12, 2013 /PRNewswire-USNewswire/ -- Generally, drug development in the U.S. is powered by pharmaceutical company laboratories. In an unusual turn of events, a promising new treatment for debilitating recurrent Clostridium difficile infection has developed outside the usual drug-development process, and the treatment isn't a chemical compound, but microbes that live in the human gut. Every year more...

2013-05-01 12:27:55

ROSEVILLE, Minn., May 1, 2013 /PRNewswire/ -- William "Bill" McGuire, M.D., former chairman and CEO of UnitedHealth Group, has joined the board of directors of Rebiotix Inc. The Roseville, Minn.-based biotechnology company is pioneering a practical and non-antibiotic treatment for recurrent Clostridium difficile infection (CDI) known as Microbiota Restoration Therapy (MRT). CDI has been linked to 14,000 deaths annually in the US, and has become the most common healthcare-associated...

2013-04-22 08:28:42

EXTON, Pa., April 22, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM), an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections (CDI). CDI is a common and dangerous gastrointestinal infection...

2013-02-14 08:29:00

JERSEY CITY, N.J., Feb. 14, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the February 2013 Journal of the American Geriatrics Society published results from a multivariate analysis demonstrating that advancing age is a predictor of deterioration in treatment outcomes in patients with Clostridium difficile infection (CDI). The analysis was performed using data from two large, randomized Phase 3 clinical studies that compared the efficacy of...

Benefits Of Fecal Transplants Highlighted In New Study
2013-01-17 11:03:14

Michael Harper for redOrbit.com — Your Universe Online It´s difficult to turn down promising options when you have a debilitating or chronic illness. It´s completely daft to turn your nose up at an option for treatment when your life is on the line. Medical science, as it often does, is once again pushing the boundaries of what that layman perceives as a last-ditch treatment option. According to a new paper published in The New England Journal of Medicine (NEJM) this...

2013-01-09 12:35:19

A synthetic "poop" developed at the University of Guelph can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium. A study on the artificial stool was published today in the inaugural issue of Microbiome, a new peer-reviewed science journal. The stool — a "super-probiotic" called RePOOPulate — was created by Guelph microbiologist Emma Allen-Vercoe to replace human fecal matter used in stool transplants, a known treatment for C....

Another Successful Poop Transplant
2012-09-26 20:20:27

John Neumann for redOrbit.com — Your Universe Online Kaitlin Hunter of Marietta GA, after a near-fatal auto accident, found herself fighting for her life against a clostridium difficile (C. diff) infection in her colon due to the June 2011 car crash. Emergency crews had to cut Hunter from her dad´s car and then she was flown to a hospital, where she found herself recovering for weeks afterwards from a fractured spine, lacerated liver and colon, and 10 broken toes. In the...